Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

KRT8 Antikörper (AA 343-357)

Dieser Maus Monoklonal Antikörper detektiert spezifisch KRT8 in IHC, IF und FACS. Es zeigt Reaktivität gegenüber Proben von Human.
Produktnummer ABIN6252474
910,25 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 6 bis 9 Werktagen

Kurzübersicht für KRT8 Antikörper (AA 343-357) (ABIN6252474)

Target

Alle KRT8 Antikörper anzeigen
KRT8 (Keratin 8 (KRT8))

Reaktivität

  • 345
  • 95
  • 90
  • 68
  • 68
  • 66
  • 65
  • 16
  • 14
  • 11
  • 9
  • 7
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
Human

Wirt

  • 178
  • 175
  • 3
Maus

Klonalität

  • 214
  • 139
  • 1
Monoklonal

Konjugat

  • 198
  • 26
  • 17
  • 8
  • 8
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Dieser KRT8 Antikörper ist unkonjugiert

Applikation

  • 258
  • 184
  • 135
  • 106
  • 71
  • 59
  • 52
  • 41
  • 41
  • 39
  • 35
  • 25
  • 23
  • 5
  • 4
  • 2
  • 2
  • 2
  • 1
  • 1
Immunohistochemistry (IHC), Immunofluorescence (IF), Flow Cytometry (FACS)

Klon

SPM192
  • Bindungsspezifität

    • 23
    • 16
    • 14
    • 12
    • 9
    • 8
    • 8
    • 7
    • 7
    • 6
    • 6
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 343-357

    Spezifität

    Does not react with rat

    Aufreinigung

    Protein G affinity chromatography

    Immunogen

    A keratin preparation from a human carcinoma was used as the immunogen for this Cytokeratin 8 antibody. The epitope of this Ab is located between amino acids 343-357.

    Isotyp

    IgG1 kappa
  • Applikationshinweise

    Flow Cytometry: 0.5-1 μg/million cells in 0.1ml

    Immunofluorescence: 1-2 μg/mL

    Immunohistochemistry (FFPE): 0.5-1 μg/mL for 30 min at RT (1)

    Prediluted format: incubate for 30 min at RT (2)

    The optimal dilution of the Cytokeratin 8 antibody for each application should be determined by the researcher.

    1. Staining of formalin-fixed tissues requires boiling tissue sections in 10  mM Citrate Buffer,  pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes.
    2. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    0.2 mg/mL

    Buffer

    PBS with 0.1 mg/mL BSA and 0.05 % sodium azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Aliquot and Store at -20C. Avoid freez-thaw cycles.
  • Target

    KRT8 (Keratin 8 (KRT8))

    Andere Bezeichnung

    Cytokeratin 8

    Hintergrund

    Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Reportedly, anti-CK8 is useful for the differentiation of lobular ('ring-like, perinuclear') from ductal ('peripheral-predominant') carcinoma of the breast.

    Gen-ID

    3856

    UniProt

    P05787
Sie sind hier:
Chat with us!